Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells.

作者: Guang-jun Hao , Hai-jun Hao , Yan-hui Ding , Hui Wen , Xiao-feng Li

DOI: 10.1002/1873-3468.12566

关键词: CancerBiologyCisplatinCancer researchLung cancermicroRNAIn vitroChemotherapyApoptosisIn vivo

摘要: Although microRNAs and EIF4G2 are both known to play pivotal roles in cancer progression, it remains unknown whether these pathways regulate chemosensitivity a coordinated manner. Here, we show that miR-379 expression is significantly downregulated chemoresistant non-small cell lung (NSCLC) tissues cells. Manipulation of levels could alter the vitro vivo cisplatin (CDDP) resistance (LCa) Mechanistically, potentiated LCa via modulation CDDP-induced apoptosis by directly targeting 3'UTR. Additionally, observed an inverse correlation between from patients with CDDP-based chemotherapy. Together, our findings shed new light on potential involvement miR-379/EIF4G2 cascade pathogenesis CDDP-resistance LCa. This article protected copyright. All rights reserved.

参考文章(25)
Chong Zhang, Jun-hao Lai, Bin Hu, Shun Zhang, Jie Zhao, Wei Li, A chromatin modifier regulates Sertoli cell response to mono-(2-ethylhexyl) phthalate (MEHP) via tissue inhibitor of metalloproteinase 2 (TIMP2) signaling. Biochimica et Biophysica Acta. ,vol. 1839, pp. 1170- 1182 ,(2014) , 10.1016/J.BBAGRM.2014.08.006
Juan Pablo Rigalli, Nadia Ciriaci, Agostina Arias, María Paula Ceballos, Silvina Stella Maris Villanueva, Marcelo Gabriel Luquita, Aldo Domingo Mottino, Carolina Inés Ghanem, Viviana Alicia Catania, María Laura Ruiz, Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0119502
KAZUO YAMAMOTO, MASAHIRO SEIKE, SUSUMU TAKEUCHI, CHIE SOENO, AKIHIKO MIYANAGA, RINTARO NORO, YUJI MINEGISHI, KAORU KUBOTA, AKIHIKO GEMMA, MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma. Oncology Reports. ,vol. 32, pp. 2365- 2372 ,(2014) , 10.3892/OR.2014.3481
Liang Yu, Yan-sheng Su, Jie Zhao, He Wang, Wei Li, Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC‐3 human prostate cancer cells FEBS Letters. ,vol. 587, pp. 2542- 2551 ,(2013) , 10.1016/J.FEBSLET.2013.06.029
Teresa Lee, Jerry Pelletier, Eukaryotic initiation factor 4F: a vulnerability of tumor cells Future Medicinal Chemistry. ,vol. 4, pp. 19- 31 ,(2012) , 10.4155/FMC.11.150
Krystyna Mazan-Mamczarz, X. Frank Zhao, Bojie Dai, James J. Steinhardt, Raymond J. Peroutka, Kimberly L. Berk, Ari L. Landon, Mariola Sadowska, Yongqing Zhang, Elin Lehrmann, Kevin G. Becker, Rita Shaknovich, Zhenqiu Liu, Ronald B. Gartenhaus, Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development. PLOS Genetics. ,vol. 10, ,(2014) , 10.1371/JOURNAL.PGEN.1004105
Toshiyuki Minami, Takashi Kijima, Satoshi Kohmo, Hisashi Arase, Yasushi Otani, Izumi Nagatomo, Ryo Takahashi, Kotaro Miyake, Masayoshi Higashiguchi, Osamu Morimura, Shoichi Ihara, Kazuyuki Tsujino, Haruhiko Hirata, Koji Inoue, Yoshito Takeda, Hiroshi Kida, Isao Tachibana, Atsushi Kumanogoh, Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis Scientific Reports. ,vol. 3, pp. 2669- 2669 ,(2013) , 10.1038/SREP02669
Saurabh V Laddha, Subhashree Nayak, Deepanjan Paul, Rajasekhara Reddy, Charu Sharma, Prerana Jha, Manoj Hariharan, Anurag Agrawal, Shantanu Chowdhury, Chitra Sarkar, Arijit Mukhopadhyay, Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers Biology Direct. ,vol. 8, pp. 10- 10 ,(2013) , 10.1186/1745-6150-8-10
Jipeng Li, Yiping Wang, Yulan Song, Zhongming Fu, Wanjun Yu, miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Molecular Cancer. ,vol. 13, pp. 193- 193 ,(2014) , 10.1186/1476-4598-13-193